Senior Director, IP Counsel
Listed on 2025-12-01
-
IT/Tech
AI Engineer, Data Security, Cybersecurity, Data Science Manager
3 days ago Be among the first 25 applicants
Get AI-powered advice on this job and more exclusive features.
About Formation Bio
Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development.
About Formation Bio
Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development.
Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as Trial Spark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials.
Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth, and others.
You Can Read More At The Following Links
- Our Vision for AI in Pharma
- Our Current Drug Portfolio
- Our Technology & Platform
About The Position
From its roots as a clinical development company, Formation Bio is harnessing the power of deep learning and artificial intelligence to break clinical development paradigms and transform how drugs and biologics are developed. We are acquiring and developing a portfolio of clinical-stage assets and looking for an IP leader who shares our vision and energy to protect, enhance, and maximize the value of these innovations throughout their entire lifecycle - from initial diligence through clinical development and eventual partnering or sale.
Our preference is for a NYC-based or Boston-based attorney who can sit in our office (we are hybrid in-office), but would be open professionals in the Northeast who can regularly come into the office and interact with various team members.
You'll be principally in charge of our patent and IP portfolio, where you will work closely with our business development, legal, clinical, CMC, and data/engineering teams to on-board products with strong IP potential, and thereafter coordinate patent and regulatory activities to deliver best-in-class IP positions. We expect this person to create and influence strategy, assist with deal and portfolio decisions, and directly impact whether our company succeeds.
Responsibilities
- Develop and execute IP strategies that maximize asset value from in-licensing through exit
- Lead IP due diligence for pharmaceutical and biologic acquisitions, identifying both risks and hidden value in complex pharma/biotech transactions
- Build IP portfolios during clinical development that strengthen our competitive position and considering potential asset exit opportunities
- Drive IP strategy and negotiation in complex pharma/biotech transactions, including working closely with our deal makers on items like strength and longevity of IP protection
- Manage relationships with outside IP law firms
- Navigate formulation findings, method of use patents, lifecycle management strategies, process-related discoveries and labeling-related IP issues
- Oversee trademark, trade secret, and data exclusivity strategies
- Advise on IP issues to multidisciplinary scientific and engineering teams, including ML/data scientists and with respect to our AI product features
- Comfortable working cross functionally, including partnering with clinical and CMC teams to identify patentable innovations during development, collaborating with BD to position IP assets for maximum strategic value, and collaborating with our AI/tech teams as we build out our…
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).